Beefing up biologics production ahead of a potential Alzheimer’s launch, Eli Lilly is plowing more than €400 million ($445.3 million) into a new manufacturing facility in Limerick, Ireland, according to IDA, the country’s inward promotion agency. The plant itself will employ more than 300 once it’s complete. Shortly after the Limerick announcement, Lilly dropped designs on another new factory—this time a $1 billion injectables facility in Concord, North Carolina, Source: Fierce Pharma 28/1/2022